Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 1041

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 11
Chunk 1041
---
 entity has the right to acquire, such as through the exercise of warrants or stock options or the vesting
of restricted stock units, within 60 days of March 28, 2025. Shares subject to warrants or options that are currently exercisable or
exercisable within 60 days of March 28, 2025 or subject to restricted stock units that vest within 60 days of March 28, 2025 are considered
outstanding and beneficially owned by the person holding such warrants, options, or restricted stock units for the purpose of computing
the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any
other person.

Except
as noted by footnote, and subject to community property laws where applicable, based on the information provided to the Company, the
persons and entities named in the table below have sole voting and investment power with respect to all shares shown as beneficially
owned by them. Unless otherwise indicated, the business address of each beneficial owner listed in the table below is c/o Conduit Pharmaceuticals
Inc., 4581 Tamiami Trail North, Suite 200 Naples, Florida 34103.

The
beneficial ownership of our Common Stock is based on 6,662,755 shares of Common Stock issued and outstanding as of March 28, 2025, which
number excludes the shares of Common Stock issuable upon exercise of the warrants. Unless otherwise indicated, we believe that all persons
named in the table have sole voting and investment power with respect to all of the shares shown to be beneficially owned by them.

    Name and Address of Beneficial Owner(1) 
    Number of shares of Common Stock  
    % of Common Stock* 

    Directors and executive officers 

    James Bligh 
     10,381(2) 
     * 

    Faith L. Charles 
     3,631(3) 
     * 

    Chele Chiavacci Farley 
     5,914(4) 
     * 

    Freda Lewis-Hall 
     34,836(5) 
     *

    Andrew Regan 
     302,926(6) 
     4.55%

    David Tapolczay 
     30,987(7) 
     *

    Simon Fry 
     2,000(8) 
     * 

    All directors and executive officers as a group (